Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

...

All

ATC	Name	B/G ↑	Ingredients	Dosage	Form	Price
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lipocream	221,734 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lipocream	221,734 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.1%	Emulsion	177,387 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.1%	Emulsion	177,387 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lotion	201,576 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lotion	201,576 L.L
N03AX09	LAMICTAL	B	Lamotrigine - 100mg	100mg	Tablet	2,741,209 L.L
N05BA08	LEXOTANIL	B	Bromazepam - 3mg	3mg	Tablet, scored	413,903 L.L
N03AX09	LAMICTAL	B	Lamotrigine - 25mg	25mg	Tablet	1,088,270 L.L
N05BA08	LEXOTANIL	B	Bromazepam - 1.5mg	1.5mg	Tablet, scored	299,677 L.L
C03CA01	LASIX	B	Furosemide - 40mg	40mg	Tablet	120,946 L.L
N03AX09	LAMICTAL LIQUI-TABS	B	Lamotrigine - 5mg	5mg	Tablet	361,046 L.L
N03AX09	LAMICTAL	B	Lamotrigine - 50mg	50mg	Tablet	1,753,895 L.L
C03CA01	LASIX	B	Furosemide - 500mg	500mg	Tablet	1,454,038 L.L
D07XC01	LOTRIDERM	B	Betamethasone (dipropionate) - 0.5mg/g, Clotrimazole - 10mg/g		Cream	470,345 L.L
N06AA21	LUDIOMIL	B	Maprotiline - 10mg	10mg	Tablet, sugar coated	867,738 L.L
L01ED05	LORBRENA	B	Lorlatinib - 25mg	25mg	Tablet	134,559,469 L.L
L01ED05	LORBRENA	B	Lorlatinib - 100mg	100mg	Tablet	403,677,371 L.L
A08AA01	LOMAIRA	B	Phentermine Hydrochloride - 8mg	8mg	Tablet	6,138,673 L.L
G04BE09	LEVITRA	B	Vardenafil (HCl) - 20mg	20mg	Tablet, film coated	2,660,808 L.L
G04BE30	LIF-DOL	B	Yohimbin HCl - 3.3mg, Thiamine - 5.5mg, Cyanocobalamine - 0.015mg, Ferrous fumarate - 50mg, Sildenafil citrate - 10mg		Tablet, coated	231,653 L.L
N02AJ14	LENIZAK	B	Tramadol HCl - 75mg, Dexketoprofen - 25mg		Tablet, film coated	494,534 L.L
J07CA	LANTIGEN B	B	Streptococcus pneumoniae type 3 (antigenic extracts) - 63.2A.U./ml, Streptococcus pyogenes group A (antigenic extracts) - 126.2A.U./ml, Branhamella catarrhalis (antigenic extracts) - 39.9A.U./ml, Staphylococcus aureus (antigenic extracts) - 79.6A.U./ml, Haemophilus influenzae type b (antigenic extracts) - 50.2A.U./ml, Klebsiella pneumoniae (antigenic extracts) - 39.8A.U./ml		Drops suspension	916,501 L.L
C10AA08	LIVAZO	B	Pitavastatin - 2mg	2mg	Tablet, film coated	1,558,857 L.L
C10AA08	LIVAZO	B	Pitavastatin - 4mg	4mg	Tablet, film coated	1,835,305 L.L
C10AB04	LOPID	B	Gemfibrozil - 600mg	600mg	Tablet, film coated	498,566 L.L
C10AB05	LIPANTHYL	B	Fenofibrate - 160mg	160mg	Tablet, film coated, modified release	1,154,238 L.L
C10AB05	LIPANTHYL 200 M	B	Fenofibrate - 200mg	200mg	Capsule	1,115,364 L.L

...